Ashe Carol Gail has filed 4 insider transactions across 2 companies since December 2023.
Most recent transaction: a grant/award of 7900 shares of Elicio Therapeutics, Inc. ($ELTX) on May 19, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 19, 2025 | Elicio Therapeutics, Inc. | $ELTX | Ashe Carol Gail | Director | A | Stock Option (Right to Buy) | 7900 | $0.00 | 7,900.0000 | 15,953,524 | 9999.99% | 0.05% |
| Nov. 21, 2024 | Elicio Therapeutics, Inc. | $ELTX | Ashe Carol Gail | Director | A | Stock Option (Right to Buy) | 4100 | $0.00 | 4,100.0000 | 0 | 9999.99% | 0.00% |
| Feb. 5, 2024 | Aptose Biosciences Inc. | $APTOF | Ashe Carol Gail | Not found | A | Director Stock Option (Right to Buy) | 3333 | $0.00 | 3,333.0000 | 0 | 9999.99% | 0.00% |
| Dec. 28, 2023 | Elicio Therapeutics, Inc. | $ELTX | Ashe Carol Gail | Not found | A | Stock Option (right to buy) | 4100 | $0.00 | 4,100.0000 | 0 | 9999.99% | 0.00% |